Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Infect Chemother ; 30(6): 548-551, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38042300

ABSTRACT

A 28-year old Japanese man with Noonan syndrome (NS) presented to our emergency department with painful erythema of the trunk and lower extremities since the previous day. He had been diagnosed with protein-losing enteropathy (PLE) with intestinal lymphangiectasia at age 25 years, and undergone lymphaticovenular anastomosis (LVA) twice. Three episodes of cellulitis of both lower extremities had occurred in the past 2 years. Extensive cellulitis with sepsis was diagnosed and piperacillin/tazobactam was started, which was de-escalated to ceftriaxone. He was discharged after 13 days of antibiotic therapy. After discharge, low-dose trimethoprim-sulfamethoxazole (SMZ-TMP) was started as the primary prophylaxis, but three episodes of cellulitis occurred in the next year and were treated with other antibiotics. NS, an autosomal dominant disease known as a RASopathy, is caused by germline mutations in RAS-MAPK pathway genes. Lymphedema resulting from lymphatic abnormalities is a concomitant manifestation in 20 % of patients with NS, and can be a risk factor for cellulitis. Hypoalbuminemia and hypoglobulinemia associated with PLE facilitate infections such as cellulitis. As a treatment for lymphedema in the extremities, LVA has shown objective and subjective improvements in most patients, and some studies have also reported its efficacy for lymphedema in patients with NS. Targeted molecular therapy with mitogen-activated protein kinase enzyme (MEK) inhibitor is used in treatment of cancers with activation of the RAS/MAPK pathway. MEK inhibitors have recently been tried in patients with RASopathies and severe lymphatic disorders, and can lead to rapid resolution of symptoms.

2.
Biosci Biotechnol Biochem ; 81(6): 1185-1193, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28485211

ABSTRACT

6-Tuliposide B (PosB) is a glucose ester accumulated in tulip (Tulipa gesneriana) as a major secondary metabolite. PosB serves as the precursor of the antimicrobial lactone tulipalin B (PaB), which is formed by PosB-converting enzyme (TCEB). The gene TgTCEB1, encoding a TCEB, is transcribed in tulip pollen but scarcely transcribed in other tissues (e.g. roots) even though those tissues show high TCEB activity. This led to the prediction of the presence of a TCEB isozyme with distinct tissue specificity. Herein, we describe the identification of the TgTCEB-R gene from roots via native enzyme purification; this gene is a paralog of TgTCEB1. Recombinant enzyme characterization verified that TgTCEB-R encodes a TCEB. Moreover, TgTCEB-R was localized in tulip plastids, as found for pollen TgTCEB1. TgTCEB-R is transcribed almost exclusively in roots, indicating a tissue preference for the transcription of TCEB isozyme genes.


Subject(s)
Carboxylic Ester Hydrolases/genetics , Gene Expression Regulation, Plant , Glucosides/metabolism , Hydroxybutyrates/metabolism , Plant Proteins/genetics , Plant Roots/enzymology , Tulipa/enzymology , 4-Butyrolactone/analogs & derivatives , 4-Butyrolactone/metabolism , Amino Acid Sequence , Anti-Infective Agents/metabolism , Biotransformation , Carboxylic Ester Hydrolases/metabolism , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression , Isoenzymes/genetics , Isoenzymes/metabolism , Kinetics , Organ Specificity , Plant Proteins/metabolism , Plant Roots/genetics , Pollen/enzymology , Pollen/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Secondary Metabolism/genetics , Substrate Specificity , Transcription, Genetic , Tulipa/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...